About this trial
The goal of this clinical trial is to find the difference in immune response between two types of regional anesthesia in female patients suffering from breast cancer.
The main question it aims to answer is there a difference in the immune response between paravertebral block and erector spinal plane block.
Hypothresis of the study is that paravertebral block with propofol induces less immune response in surgical treatment of breast cancer patients than erector spinal plane block.
Participants will be asked to sign the informant consent. They will be given either paravertebral block or erector spinae plane block with general anesthesia using propofol. Their venous blood will be taken 1 hour prior surgery and 24 and 48 hours after surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
ASA I and ASA II status, normal BMI
Disqualifiers
ASA III and ASA IV status, coagulopathy, chronic opioid use, diabetes, local infection of the skin
Trial design
Parallel
Treatments tested in this trial
Regional Anesthetic Injection
Procedure/SurgeryDraw of venous blood and application of paravertebral and erector spinae plane block
Blood draw for the laboratory assessment
Procedure/SurgeryDraw of venous blood 24 hours after surgery
Blood draw for the laboratory assessment
Procedure/SurgeryBlood draw 48 hours after surgery
Treatment groups
Trial outcomes
Primary outcomes
Immune response in two different regional anesthesia techniques
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: